North Central Cancer Treatment Group, Illinois Cancer Care — Peoria, Illinois

North Central Cancer Treatment Group, Illinois Cancer Care is a clinical research site located in Peoria, Illinois, United States 61615-7822.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

North Central Cancer Treatment Group, Illinois Cancer Care has participated in 1 clinical trials.

Therapeutic areas: Metastatic Renal Cell Carcinoma.

Sponsors: Immatics Biotechnologies GmbH.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for North Central Cancer Treatment Group, Illinois Cancer Care?

North Central Cancer Treatment Group, Illinois Cancer Care has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has North Central Cancer Treatment Group, Illinois Cancer Care conducted?

North Central Cancer Treatment Group, Illinois Cancer Care has 1 clinical trials on record. Their work covers Metastatic Renal Cell Carcinoma.

Is North Central Cancer Treatment Group, Illinois Cancer Care accredited by Crixeo Health?

North Central Cancer Treatment Group, Illinois Cancer Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about North Central Cancer Treatment Group, Illinois Cancer Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.